SCHEMBL31104367

SCHEMBL31104367

Cc1c(Br)ccc(C=O)c1F

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.35
PRKDC P78527 1/20 0.34
KCNJ1 P48048 2/20 0.34
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
THRB P10828 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ERN1 O75460 5/20 0.31
TRIM24 O15164 1/20 0.31
TRIM33 Q9UPN9 1/20 0.31
CYP2A6 P11509 1/20 0.31
ALDH1A3 P47895 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19862054 1.00 ALDH1A1 (0.35) ALDH1A1TSHRPRKDCKCNJ1LMNA
SCHEMBL26050997 0.83 KCNJ1 (0.36) ALDH1A1TSHRPRKDCKCNJ1LMNA
SCHEMBL898807 0.80 TDP1 (0.36) ALDH1A1TSHRPRKDCKCNJ1LMNA
SCHEMBL29390677 0.80 TDP1 (0.36) ALDH1A1TSHRPRKDCKCNJ1LMNA
SCHEMBL6015132 0.80 ALDH1A1 (0.39) ALDH1A1TSHRPRKDCKCNJ1LMNA
SCHEMBL584614 0.78 ERN1 (0.42) ALDH1A1TSHRKCNJ1LMNAMEN1
SCHEMBL6438818 0.78 ALDH1A1 (0.43) ALDH1A1TSHRKCNJ1LMNAMEN1
SCHEMBL30065195 0.77 ALDH1A1 (0.41) ALDH1A1TSHRPRKDCKCNJ1LMNA
SCHEMBL19641559 0.77 ALDH1A1 (0.41) ALDH1A1TSHRPRKDCKCNJ1LMNA
SCHEMBL25250329 0.75 ERN1 (0.39) ALDH1A1TSHRPRKDCLMNAERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119384413-A Anilino-pyrazole derivatives, compositions and methods thereof 昂胜医药有限公司 2025-01-28 CN disclosed
WO-2024182693-A1 2-AZASPIRO[3.3]HEPTANE DERIVATIVES AS STAT3 INHIBITORS FOR THE TREATMENT OF CANCER VIVIDION THERAPEUTICS, INC. (US) 2024-09-06 WO disclosed